Essential hypertension is the leading risk factor for cardiovascular disease, which is a serious threat to human health. 1, 2 Much effort has been devoted to studying the pathogenesis of hypertension; however, the mechanisms through which hypertension develops are complicated and remain largely unknown. Studies have demonstrated that many environmental factors can affect the development of the fetus and may also play a role in the development of many diseases that arise during adulthood, including hypertension, diabetes, and obesity. 3 These findings are supported by the results of global epidemiological investigations. 4 Lipopolysaccharide (LPS) is a toxic component of the cell walls of gram-negative bacteria, which are present in the digestive tracts of animals and humans, and its administration induces wellestablished models of bacterial infection. 5 According to the findings of current studies, fetal exposure to LPS can lead to the development of many chronic adult diseases, such as hypertension. [6] [7] [8] The renin-angiotensin system (RAS), which comprises renin, angiotensin (Ang), and Ang receptors, plays a key role in regulating blood pressure. This pathway facilitates the normal physiological functions of the cardiovascular system Prenatal Exposure to LPS Alters The Intrarenal RAS in Offspring, Which Is Ameliorated by Adipose Tissue-Derived Mesenchymal Stem Cells Xian-Fei Ding, 1,2, * Mou Sun, 1,2, * Fang-Xia Guan, 3 Li-Na Guo, 4 Yan-Yan Zhang, 1,2 You-Dong Wan, 1,2 Xiao-Juan Zhang, 1,2 Yan-Wu Yu, 1,2 Shan-Shan Ma, 3 Hai-Mu Yao, 5 Rui Yao, 5 6 Tong-Wen Sun, 1,2 and Quan-Cheng Kan 7 BACKGROUND Prenatal lipopolysaccharide (LPS) exposure causes hypertension in rat offspring through an unknown mechanism. Here, we investigated the role of the intrarenal renin-angiotensin system (RAS) in hypertension induced by prenatal LPS exposure and also explored whether adipose tissue-derived mesenchymal stem cells (ADSCs) can ameliorate the effects of prenatal LPS exposure in rat offspring.
and also participates in the pathogenesis of hypertension. 9 Ang II is a key constituent of the RAS and also participates in inflammation by increasing vascular permeability, inflammatory cell recruitment, and immunocompetent cell differentiation and proliferation. Moreover, Ang II is also a chemoattractant for inflammatory cells in the kidney. 10 Ang II exerts its biological effects by binding to its specific receptors, such as the Ang II type 1 receptor (AT1R), in mature tissues. 11 The AT1R is responsible for mediating many wellknown pathological processes and has several tissue-specific functions, as it promotes aldosterone secretion, renal sodium reabsorption, and vasoconstriction, all of which can lead to elevations in blood pressure. 12 Adipose tissue-derived mesenchymal stem cells (ADSCs), which are multipotent mesenchymal stem cells, can be easily isolated from adipose tissue and then differentiated into endothelial cells, adipocytes, and myocytes. They may also be useful in the repair and regeneration of acutely and chronically damaged tissues. 13 More importantly, ADSCs can be autologously transplanted; thus, their use is not constrained by ethics regulations. 14 Moreover, the risk of immune rejection associated with their use is greatly reduced compared with that associated with the use of other types of stem cells. 13 ADSCs display the typical characteristics of mesenchymal stem cells, as determined by the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy. 15 To date, there have been 15 clinical trials regarding the use of ADSCs in cardiovascular disease. 16 However, currently, the data are limited regarding the involvement of mesenchymal stem cells in the pathophysiology of essential hypertension.
In our preliminary experiment, we found that exposing pregnant rats to LPS resulted in elevated blood pressure in their offspring. Interestingly, ADSCs treatment attenuated the blood pressure increases elicited by prenatal exposure to LPS and also ameliorated LPS-induced histological and pathological changes in the kidney of rat offspring. However, the mechanisms underlying the above phenomena remain to be elucidated. Does the RAS play a role in the development of prenatal LPS exposureinduced hypertension in rat offspring? Moreover, how do ADSCs attenuate LPS exposure-induced hypertension? In this study, we aimed to answer these questions.
We treated pregnant rats with LPS and then treated their offspring with ADSCs. We subsequently studied the effects of the above treatments on systolic blood pressure (SBP), renal and cardiac histology, plasma RAS levels, renal function, Ang II protein expression levels, Ang II-positive cell counts, and inflammatory cell levels in kidney tissues.
METHODS

Animals
This study was conducted in accordance with the principles outlined in the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (http://grants1. nih.gov/grants/olaw/), and the experimental protocols used herein were approved by the Life Sciences Ethics Review Committee of Zhengzhou University. Sixty-four pregnant, nulliparous, and time-mated SD rats (with an average body weight of 250-270 g) were purchased from the Beijing Vital River Laboratory Animal Technology (Beijing, China). All the animals had free access to standard laboratory rat chow and tap water. The rats were housed individually in a room with a constant temperature (24 °C) and under a 12-hour light-dark cycle until they were ready to give birth. After parturition, the pups were housed with their mothers until 4 weeks of age, at which time they were placed in different cages. 7 
Cell line and cell culture
ADSCs from inguinal fat were purchased from the Cyagen Biotechnology (Yangzhou, China). These cells were cultured in complete culture medium supplemented with 100 IU/ml penicillin, 100 µg/ml streptomycin, 10% fetal bovine serum, and glutamine at 37 °C in a humidified atmosphere containing 5% CO 2 . All experimental cells were in the logarithmic phase of growth.
Dams and litters
Sixty-four pregnant rats were randomly divided into 4 groups (n = 16 in each), namely, a control group, an LPS group (Sigma Chemical, St Louis, MO), an LPS + ADSCs group, and an ADSCs group (Cyagen Biotechnology). The pregnant rats in the LPS group were intraperitoneally injected with 0.79 mg/kg LPS on the 8 th , 10 th , and 12 th days of gestation, and the rats in the ADSCs group were injected with ADSCs (1.8 × 10 7 cells per animal) via the tail vein on the 8 th , 10 th , and 12 th day of gestation. The rats in the LPS + ADSCs group received both of the above treatments. The rats in the control group were intraperitoneally injected with 0.79 mg/ kg normal saline. Each pregnant rat was used only once. After the neonatal rats (n = 36 in each group) were delivered, they were cared for by their mothers until they were weaned, at which time they began receiving standard rat chow. The weight of each rat, as well as the mean number of progeny per pregnant rat in each treatment group, was determined when the offspring were 1 day old. The neonatal rats were used in subsequent experiments. A specific flow chart detailing the various stages of our study is shown in Figure 1d .
SBP measurements
SBP was measured in rats aged 6-16 weeks using the tailcuff method 7 (BP 2010A, Softron Biotechnology, Tokyo, Japan). Before the measurements, the rats were placed inside a warming chamber (approximately 34 °C) for 15 minutes to induce tail vasodilation. The rats were then placed in plastic restraints, and cuffs with pneumatic pulse sensors were attached to their tails. The rats were exposed to the procedure at least 3 times before their blood pressures were formally measured. The mean SBP for each rat was calculated from 3 consecutive SBP measurements.
Sample collection and plasma RAS concentration and renal function measurements
The neonatal rats were killed rapidly by decapitation, and then their kidneys were excised. Briefly, rats aged 7 and 16 weeks were anesthetized with 10% chloral hydrate (350 mg/ kg), after which blood samples were collected by left ventricular puncture. The rats were subsequently euthanized, and their hearts and kidneys were excised. Plasma RAS concentrations were measured by chemiluminescence [17] [18] [19] [20] using Ang I and II in vitro diagnostic kits (Snibe, Shenzhen, China) and a fully automated chemiluminescence immunoassay analyser (MAGLUMI 2000 Plus, Snibe).We assessed renal function by measuring serum creatinine, urea nitrogen, uric acid, β 2 -MG, and cys-c concentrations. Serum urea nitrogen concentrations were determined by the UV-Glutamate Dehydrogenase method using a UREAL assay kit, and serum creatinine concentrations were determined by the sarcosine oxidase method using a Creatinine Assay Kit Plus Ver.2. Serum uric acid concentrations were determined by the oxidase method using a Uric Acid Assay Kit Ver.2, and serum β 2 -MG and cys-c concentrations were determined by latex immunoturbidimetry using β 2 -MG and Cystatin C assay kits and an automated biochemical analyser (Cobas 8000, Roche Diagnostics GmbH, Mannheim, Germany). All the kits were purchased from Roche Diagnostics GmbH, Germany.
Histology
HE staining was performed to assess renal histology in samples from 16-week-old rat offspring. The tissues were fixed in 4% paraformaldehyde, embedded in paraffin, and then cut into 4-µm sagittal sections. The sections were subsequently stained with HE, and renal tubular and interstitial histology was evaluated microscopically.
IHC staining
Intrarenal Ang II-positive cells, 17, 21 monocytes/macrophages, and lymphocytes were identified by IHC staining in neonatal rats. Anti-CD68, a monoclonal antibody (Suzhou Rui Ying Biotechnology, Suzhou, China) specific for monocytes/macrophages, was used to identify the monocytes/macrophages, and an anti-CD5 monoclonal antibody (Suzhou Rui Ying Biotechnology) was used to identify the lymphocytes. 22 Kidney tissue sections were rinsed and rehydrated in phosphate buffered saline for 5 minutes. The sections were then subjected to indirect immunoperoxidase staining using Two-step IHC Detection Reagent (Beijing Solleys Technology, Beijing, China). Endogenous peroxidase was inhibited by treatment with 3% H 2 O 2 in phosphate buffered saline for 15 minutes. The sections were subsequently treated with blocking solution containing 5% bovine serum albumin for 15 minutes at room temperature to reduce nonspecific binding by the biotinylated antibody before being incubated with primary mouse anti-monoclonal Ang II/ III antibodies (1:200, Novus Biologicals) or mouse anti-CD68 and anti-CD5 monoclonal antibodies for 12 hours at 4 °C. The sections were then incubated with goat antimouse IgG/HRP secondary antibodies (ab6789, Abcam, Cambridge, UK) for 30 minutes at 37 °C. Peroxidase activity was visualized with a diaminobenzidine kit (Beijing Solleys Figure 1 . The effects of prenatal exposure to LPS or ADSCs on progeny numbers and weight and MSBP in offspring. There were no significant differences in the mean number of progeny per pregnant rat (a) or neonatal weight among the groups (n = 36) (b). LPS significantly increased MSBP levels in the corresponding group compared with the control group; however, ADSCs reduced MSBP levels in the corresponding group compared with the LPS group beginning at 6 weeks post-birth (c). Schematic representation of each phase of the study (d). The data are represented as the mean ± SEM. **P < 0.01compared with the control group. # P < 0.05 compared with the LPS group. Abbreviations: ADSCs, adipose tissue-derived mesenchymal stem cells; LPS, lipopolysaccharide; MSBP, mean systolic blood pressure.
Technology, Beijing, China), and the reaction was stopped by rinsing the sections in phosphate buffered saline. The slides were then dehydrated, mounted in aqueous mounting medium, and examined by light microscopy. The numbers of Ang II-positive cells and apoptotic cells and the mean optical densities of the inflammatory cells were determined independently by 2 blinded investigators using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD).
Apoptosis
TUNEL was used to identify apoptotic cells in the kidney sections from the neonatal and 7-week-old rats. An In Situ Cell Death Detection Kit (Roche Applied Science, Penzberg, Germany) was used to determine the numbers of DNA strand breaks in the paraffin-embedded kidney sections. TUNEL-positive nuclei were visualized with diaminobenzidine and counterstained with hematoxylin. Positive staining in each slide was assessed independently by 2 blinded investigators using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD).
Western blotting
Renal cortical lysates were prepared from 7-and 16-weekold rat offspring, and the protein concentrations were measured by BCA assay. After being denatured and electrophoresed on sodium dodecyl sulfate-polyacrylamide gels, the separated proteins were transferred to nitrocellulose membranes, which were blocked in 5% nonfat milk in trisbuffered saline containing Tween (TBST) for 1 hour. After incubating with the appropriate primary antibodies, namely, mouse anti-AT1Rantibodies (ab9391, Abcam), in TBST at 4 °C overnight, the membranes were incubated with mouse anti-alpha tubulin antibodies (ab7291, Abcam) in TBST for 1 hour at room temperature. Specific bands were detected by chemiluminescence and recorded on X-ray film, and the intensities of the bands were quantified by Quantity One software (Bio-Rad).
Statistical analysis
The results are expressed as the mean ± SEM. One-way analysis of variance and Tukey's post hoc test were used to assess the differences among the groups, and P <0.05 was considered significant. All analyses were performed using SPSS 21.0 (SPSS, Chicago, IL).
RESULTS
Dams and litters
There were no fatalities or miscarriages during pregnancy in the control or ADSCs groups; however, 5 fetuses died in the LPS group, and 4 fetuses died in the LPS + ADSCs group. Therefore, the mortality rate in pregnant rats exposed to LPS was 28.13%. Four pups were aborted in the LPS group, and 6 pups were aborted in the LPS + ADSCs group. Thus, the abortion rate in rats exposed to LPS + ADSCs was approximately 50%, which was higher than the abortion rates in rats exposed to LPS (36.4%) and ADSCs (0%).
There was no significant difference in the mean number of progeny per pregnant rat among the 4 groups (the mean numbers of progeny per pregnant rat for the control, LPS, LPS + ADSC, and ADSC groups were 14.00 ± 2.08, 12.60 ± 1.96, 8.67 ± 3.71, and 14.00 ± 1.38, respectively; P > 0.05; Figure 1a ). In addition, neonatal body weight did not differ significantly among the 4 groups (the mean body weights of the control, LPS, LPS + ADSC, and ADSC groups were 7.98 ± 0.25, 8.47 ± 0.38, 8.61 ± 0.49, and 7.77 ± 0.16, respectively; P > 0.05; Figure 1b) .
MSBP in adult offspring
The MSBPs of the offspring were measured once every 2 weeks between 6 and 16 weeks after birth, and the offspring who were exposed to LPS prenatally displayed elevated MSBPs from 8 to 16 weeks after birth. At 16 weeks after birth, the MSBP of the LPS group was 132.30 ± 8.381 mm Hg and was significantly higher than that of the control group (111.50 ± 5.148 mm Hg, P < 0.01). However, the MSBP of the LPS + ADSCs group (124.40 ± 7.058 mm Hg, P < 0.05; Figure 1c ) was significantly lower than that of the LPS group.
Plasma RAS concentrations and renal function in adult offspring
No significant differences in plasma RAS concentrations, serum creatinine concentrations, urea nitrogen concentrations, uric acid concentrations, and cys-c concentrations were noted among the 4 groups at 7 and 16 weeks after birth (Table 1 ). In addition, serum β 2 -microglobulin levels were undetectable in the 4 groups at the indicated time points.
Histology, IHC staining, TUNEL, and western blotting results in adult offspring
HE staining showed that there were no significant differences in kidney histology, as demonstrated by light microscopy, among the 4 groups (Figure 2a ) at 16 weeks after birth. However, histological analysis showed that disrupted kidney structures, mild renal tubular edema, and decreased cell nuclei numbers were visible in the LPS group. The renal tubular lumina were slightly enlarged in the LPS + ADSCs group; however, the severity of this phenotype was significantly ameliorated in the indicated group compared with the LPS group.
Ang II expression levels in the LPS group were significantly higher than those in the control group at 7 weeks after birth. Moreover, the difference in Ang II expression between the 2 groups increased from 7 to 16 weeks post-birth, as demonstrated by IHC staining (Figure 2b,c) . However, ADSCs treatment significantly decreased Ang II expression levels in the corresponding group compared with the LPS group (Figure 2b,c) . The size of the Ang II-positive cell population, which comprised mainly proximal tubular cells, was determined using Image-Pro Plus software at high magnification. The number of Ang II-positive cells in the LPS group was significantly increased compared with that in the control group at 7 (P < 0.01) and 16 weeks post-birth (P < 0.001; Figure 2b,c) . However, the number of Ang II-positive cells in the LPS + ADSC group was significantly lower than that in the LPS group (P < 0.05; Figure 2b,c) .
IHC staining showed that limited numbers of infiltrating monocytes/macrophages (Figure 3a) and lymphocytes ( Figure 3b) were visible in the renal interstitium of 1-dayand 7-week-old rats in the control group; however, large numbers of infiltrating monocytes/macrophages and lymphocytes were visible in the renal interstitium of 1-day-and 7-week-old rats in the LPS group. Treatment with ADSCs significantly attenuated these abnormalities.
TUNEL staining revealed that the majority of tubular cells that underwent apoptosis were glomerular endothelial cells. More TUNEL-positive cells were noted in the LPS group than in the control group at 1 day and 7 weeks post-birth (Figure 3e) . In contrast, the number of apoptotic bodies in kidneys treated with ADSCs was significantly decreased compared with that in kidneys treated with LPS ( Figure 3f ).
Western blotting showed that AT1R protein expression levels in the renal cortex of the LPS group were higher than those in the renal cortex of the control group at 6 and 16 weeks after birth (P < 0.001, P < 0.01, respectively; Figure 2b ,d,e). However, ADSC treatment significantly attenuated the increases in AT1R protein expression induced by LPS (Figure 2b,d,e) , as AT1R protein expression levels in the LPS + ADSCs group were significantly reduced compared with those in the LPS group (P < 0.01, P < 0.05, respectively; Figure 2b ,d,e).
DISCUSSION
In this study, we found that prenatal exposure to LPS activates the intrarenal RAS to induce increases in blood pressure in adult rat offspring; however, ADSCs treatment attenuated the blood pressure increases resulting from LPS exposure and ameliorated the other phenotypic changes induced by LPS by inhibiting intrarenal RAS activation.
First, SBP levels increased from 8 to 16 weeks post-birth in offspring exposed to LPS prenatally in our study, findings consistent with those of the studies by Wei 7 and Gao. 8 The LPS dosage, injection site, and blood pressure measurement method utilized by these authors were identical to those used by our group. Thus, the similarities between their results and ours may indicate that our results pertaining to blood pressure levels are reliable. Second, more pregnant rats were included in each group in our study than in the studies by Wei 7 and Gao 8 (16 vs. 8) , indicating that our experimental results were stable. Additionally, the most recent study by Gao 8 focused primarily on the relationship between the adipose tissue RAS and hypertension, while ours focused on the relationship between the intrarenal RAS and hypertension. Both studies focused on hypertension induced by activation of a local tissue RAS rather than hypertension induced by activation of the circulating RAS. In addition, our study was the first to assess the relationship between mesenchymal stem cells and hypertension in animals. Table 1 . Effects of prenatal exposure to LPS and ADSCs on plasma RAS levels and renal function in offspring In our study, circulating RAS levels did not change significantly with increases in SBP; however, Ang II expression levels and inflammatory cell infiltration in kidney tissues increased in conjunction with increases in SBP. These results are consistent with those of a previous study, 23 which showed that blood pressure levels were negatively correlated with plasma Ang II expression levels and positively correlated with renal Ang II expression levels in a salt-sensitive hypertension model. In Ang II-dependent hypertension, AT1R blockade increased plasma Ang II levels but significantly restricted the increases in kidney Ang II levels induced by chronic Ang II infusions. 24 All of these findings indicated that intrarenal Ang II expression levels are regulated in a manner distinct from that in which circulating Ang II levels are regulated.
The intrarenal RAS is a complete RAS that exists independently in the kidney and does not depend on the circulatory system. In this study, intrarenal RAS activity measurements showed that prenatal exposure to LPS significantly increased Ang II expression levels and Ang II-positive cell numbers in offspring and that renal Ang II expression levels were positively correlated with Ang II-positive cell numbers-particularly tubular cell numbers-and inflammatory cell numbers. These findings suggested that LPS activated the intrarenal RAS. Therefore, we speculated that prenatal exposure to LPS increased blood pressure in offspring by activating the intrarenal RAS. In addition, we found that ADSCs treatment attenuated LPSinduced increases in blood pressure, most likely by inhibiting intrarenal RAS activation, a phenomenon that has not been reported previously. However, the relationship among LPS exposure, the intrarenal RAS and blood pressure remains unclear and warrants investigation in future studies.
Several of our other findings also require further investigation. First, the mortality rate in pregnant rats exposed to Figure 3 . LPS promoted inflammatory cell infiltration and apoptosis in kidney tissues in 1-day-and 7-week-old rat offspring. IHC staining showing that numerous monocytes/macrophages (a, b) and lymphocytes (c, d) had infiltrated the renal interstitium. The mean optical density was quantified. TUNEL staining revealing that the apoptotic cells were tubular cells, namely, glomerular endothelial cells (e, f). The number of apoptotic cells or bodies was quantified (g, h). ***P < 0.001 compared with the control group. # P < 0.05, ### P < 0.001 compared with the LPS group. The data are represented as the mean ± SEM. bar = 50 µm. n = 12 in each group of 1-day-and 7-week-old rat offspring. Abbreviations: ADSCs, adipose tissue-derived mesenchymal stem cells; LPS, lipopolysaccharide.
LPS was 28.13% in this study, a rate that was significantly higher than that in other studies (10-20%). LPS-related mortality maybe rat strain-specific. Second, there were no significant differences in neonatal weight among the 4 groups, a finding consistent with those of the study by Poggi et al. 25 We are unable to explain this result but speculate that weight may differ significantly among different groups of adult rats exhibiting renal diseases of different severities. Third, there was no significant difference in adult renal function among the 4 groups. In clinical practice, reductions in renal function are a sign of end-stage hypertension and do not occur in the early stage of the disease. Sixteen-week-old offspring are younger rats. Therefore, it is reasonable that the renal function of the 16-week-old rats evaluated herein was normal. Additionally, the mean number of progeny per pregnant rat was not significantly different among the 4 groups in our study, a finding consistent with those of the study by Wei 7 ; however, the mean number of progeny per rat in the LPS + ADSCs group was lower than that in the LPS group. Moreover, the prevalence of miscarriage in the LPS + ADSC group was higher than that in the LPS group. This finding may be attributable to excess stress induced by the combined effects of treatment with ADSCs and LPS. 26, 27 ADSCs are safe, nontumor forming, and easily isolated and have a high capacity for expansion in vitro; thus, they may be a promising and effective alternative therapy for essential hypertension. Although questions remain regarding the use of ADSCs as a treatment for essential hypertension, they have shown promise as a treatment for the disease.
